The rise of copyright’s blockbuster initially drove a boom for the drug industry, but recent shifts present a murky scenario for investors. Off-patent alternatives are reducing earnings, and persistent patent https://macietdwj068972.articlesblogger.com/63569568/viagra-and-big-pharma-a-volatile-play